Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators

por Marrocco, Ilaria, Yarden, Yosef
Publicado 2023

The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors

por Schneider, Marlon R., Yarden, Yosef
Publicado 2015

Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy

por Amit, Ido, Wides, Ron, Yarden, Yosef
Publicado 2007

MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression

por Kedmi, Merav, Sas-Chen, Aldema, Yarden, Yosef
Publicado 2015

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance

por Uribe, Mary Luz, Marrocco, Ilaria, Yarden, Yosef
Publicado 2021

Roles for growth factors and mutations in metastatic dissemination

por Nataraj, Nishanth Belugali, Marrocco, Ilaria, Yarden, Yosef
Publicado 2021

The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment

por Verduci, Lorena, Strano, Sabrina, Yarden, Yosef, Blandino, Giovanni
Publicado 2019

The key roles of cancer stem cell-derived extracellular vesicles

por Su, Chaoyue, Zhang, Jianye, Yarden, Yosef, Fu, Liwu
Publicado 2021

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

por Wang, Xueping, Wang, Fang, Zhong, Mengjun, Yarden, Yosef, Fu, Liwu
Publicado 2020

CircRNAs: role in human diseases and potential use as biomarkers

por Verduci, Lorena, Tarcitano, Emilio, Strano, Sabrina, Yarden, Yosef, Blandino, Giovanni
Publicado 2021

The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediate...

por Tóth, Gábor, Szöőr, Árpád, Simon, László, Yarden, Yosef, Szöllősi, János, Vereb, György
Publicado 2016

Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor

por Enuka, Yehoshua, Lauriola, Mattia, Feldman, Morris E., Sas-Chen, Aldema, Ulitsky, Igor, Yarden, Yosef
Publicado 2016

Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma

por Singh, Anamika, Erijman, Ariel, Noronha, Ashish, Kumar, Hemant, Peleg, Yoav, Yarden, Yosef, Shifman, Julia M.
Publicado 2021

Context-specific microRNA analysis: identification of functional microRNAs and their mRNA targets

por Bossel Ben-Moshe, Noa, Avraham, Roi, Kedmi, Merav, Zeisel, Amit, Yitzhaky, Assif, Yarden, Yosef, Domany, Eytan
Publicado 2012

Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma

por Hedegger, Kathrin, Blutke, Andreas, Hommel, Theresa, Auer, Kerstin E., Nataraj, Nishanth B., Lindzen, Moshit, Yarden, Yosef, Dahlhoff, Maik
Publicado 2023

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

por Gelfo, Valerio, Mazzeschi, Martina, Grilli, Giada, Lindzen, Moshit, Santi, Spartaco, D’Uva, Gabriele, Győrffy, Balázs, Ardizzoni, Andrea, Yarden, Yosef, Lauriola, Mattia
Publicado 2018

A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis

por Lindzen, Moshit, Carvalho, Silvia, Starr, Alex, Ben-Chetrit, Nir, Pradeep, Chaluvally-Raghavan, Köstler, Wolfgang J., Rabinkov, Aaron, Lavi, Sara, Bacus, Sarah S., Yarden, Yosef
Publicado 2011

Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli

por Zeisel, Amit, Köstler, Wolfgang J, Molotski, Natali, Tsai, Jonathan M, Krauthgamer, Rita, Jacob-Hirsch, Jasmine, Rechavi, Gideon, Soen, Yoav, Jung, Steffen, Yarden, Yosef, Domany, Eytan
Publicado 2011

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits

por Giacomelli, Chiara, Jung, Janine, Wachter, Astrid, Ibing, Susanne, Will, Rainer, Uhlmann, Stefan, Mannsperger, Heiko, Sahin, Özgür, Yarden, Yosef, Beißbarth, Tim, Korf, Ulrike, Körner, Cindy, Wiemann, Stefan
Publicado 2021

Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models

por Marrocco, Ilaria, Romaniello, Donatella, Vaknin, Itay, Drago‐Garcia, Diana, Oren, Roni, Uribe, Mary Luz, Belugali Nataraj, Nishanth, Ghosh, Soma, Eilam, Raya, Salame, Tomer‐Meir, Lindzen, Moshit, Yarden, Yosef
Publicado 2021